SCHEMBL34469931

SCHEMBL34469931

CCn1cc(C(=O)OC)cc1-c1ccc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 1/20 0.44
▸ NPC1 O15118 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ MAPK14 Q16539 3/20 0.39
▸ ATM Q13315 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34469897 0.85 KDM4A (0.46) NPC1RAB9ALMNASMN1; SMN2ALDH1A1
SCHEMBL34469989 0.83 ALPL (0.50) ALPLNPC1MAPTRAB9ALMNA
SCHEMBL34469802 0.83 CHRNA7 (0.46) NPC1MAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL25314484 0.82 ALPL (0.46) ALPLNPC1MAPTRAB9ALMNA
SCHEMBL34469560 0.80 ALPL (0.47) ALPLNPC1MAPTRAB9ALMNA
SCHEMBL34469664 0.78 GABRA5 (0.42) NPC1MAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL25999949 0.74 KDM4E (0.48) NPC1MAPTRAB9AALDH1A1KDM4E
SCHEMBL34470148 0.72 ALDH1A1 (0.41) ALPLNPC1MAPTRAB9ALMNA
SCHEMBL3744170 0.72 PTGS1 (0.57) ALPLNPC1MAPTRAB9ALMNA
SCHEMBL21544796 0.71 NPC1 (0.49) ALPLNPC1MAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 — — WO disclosed
Send feedback